Company attributes
Venture Capital Firm attributes
Other attributes
Founded in 2008, Broadview Ventures is a Boston, Massachusetts based venture capital firm and an accelerator based in Boston, Massachusetts. The firm focuses on impact investing in companies operating in the technology for the diagnosis and treatment of cardiovascular and neurovascular disease along with other healthcare sectors. They prefers to invest in companies based in the United States and Europe.
The Foundation Leducq, based in Paris, France, has made funds available to Broadview Ventures to invest in and promote early state technology in the fields of cardiovascular and neurovascular disease through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support. With this initiative the trust joins other leaders in the venture philanthropy movement in seeking solutions to the problem of what is commonly referred to as the 'translational gap', a component of which is a lack of funding at a critical moment in the development of new technology and science.
Broadview Ventures has made investments in CroíValve, Renovacor, AtaCor Medical, Vectorious Medical Technologies, Adient Medical, Mellitus, CellAegis Devices, NIDO and Aeromics.
They exited their investments in Capricor Therapeutics, MiRagen, Apama Medical, CardiAQ Valve Technologies and Remedy Pharmaceuticals.
